Kang, M., Sohn, J., Cha, M., Kim, Y. H., Hong, Y., Im, H., & Cho, S. (2025). One-Year Compliance After Calcitonin Gene-Related Peptide Monoclonal Antibody Therapy for Migraine Patients in a Real-World Setting: A Multicenter Cross-Sectional Study. Journal of Clinical Medicine, 14(3), 734. https://doi.org/10.3390/jcm14030734
Chicago Style (17th ed.) CitationKang, Mi-kyoung, Jong-Hee Sohn, Myoung-Jin Cha, Yoo Hwan Kim, Yooha Hong, Hee-Jin Im, and Soo-Jin Cho. "One-Year Compliance After Calcitonin Gene-Related Peptide Monoclonal Antibody Therapy for Migraine Patients in a Real-World Setting: A Multicenter Cross-Sectional Study." Journal of Clinical Medicine 14, no. 3 (2025): 734. https://doi.org/10.3390/jcm14030734.
MLA (9th ed.) CitationKang, Mi-kyoung, et al. "One-Year Compliance After Calcitonin Gene-Related Peptide Monoclonal Antibody Therapy for Migraine Patients in a Real-World Setting: A Multicenter Cross-Sectional Study." Journal of Clinical Medicine, vol. 14, no. 3, 2025, p. 734, https://doi.org/10.3390/jcm14030734.